000 | 01698 a2200553 4500 | ||
---|---|---|---|
005 | 20250515001208.0 | ||
264 | 0 | _c20051213 | |
008 | 200512s 0 0 eng d | ||
022 | _a0028-2685 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJunghanss, C | |
245 | 0 | 0 |
_aMultivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression. _h[electronic resource] |
260 |
_bNeoplasma _c2005 |
||
300 |
_a402-10 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcute Disease _xtherapy |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntigens, CD34 _xmetabolism |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 | _aChromosome Aberrations |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaryotyping |
650 | 0 | 4 |
_aLeukemia, Myeloid _xgenetics |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aPalliative Care |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aWaak, M | |
700 | 1 | _aKnopp, A | |
700 | 1 | _aKleine, H D | |
700 | 1 | _aKundt, G | |
700 | 1 | _aLeithäuser, M | |
700 | 1 | _aHilgendorf, I | |
700 | 1 | _aWolff, D | |
700 | 1 | _aCasper, J | |
700 | 1 | _aFreund, M | |
773 | 0 |
_tNeoplasma _gvol. 52 _gno. 5 _gp. 402-10 |
|
999 |
_c15785982 _d15785982 |